{
    "company_name": "AROVELLA THERAPEUTICS LIMITED",
    "address": "Suite 1, Level 3, 62 Lygon Street, CARLTON, VIC, AUSTRALIA, 3053",
    "summary": "A biotechnology company focused on developing its invariant Natural Killer T (iNKT) cell platform for cancer treatment.",
    "details": "A biotechnology company focused on developing its invariant Natural Killer T (iNKT) cell platform for cancer treatment.",
    "website": "https://www.arovella.com",
    "stock_code": "ALA",
    "links": "['/cart', '#page', '/', '/about', '/mission-statement', '/our-team', '/governance', '/technology', '/what-are-inkt-cells', '/what-are-inkt-cells/#block-65d419627ae2d198359f3796', '/publications-conference-proceedings', '/products', '/pipeline', '/ala-101-car19-inkt', '/ala-105-cldn182-inkt', '/investors', '/investor-centre', '/asx-announcements', '/news-presentations', '/annual-reports', '/esg-reports', '/contact', '/', '/about', '/mission-statement', '/our-team', '/governance', '/technology', '/what-are-inkt-cells', '/what-are-inkt-cells/#block-65d419627ae2d198359f3796', '/publications-conference-proceedings', '/products', '/pipeline', '/ala-101-car19-inkt', '/ala-105-cldn182-inkt', '/investors', '/investor-centre', '/asx-announcements', '/news-presentations', '/annual-reports', '/esg-reports', '/contact', '/about', '/', '/mission-statement', '/our-team', '/governance', '/technology', '/', '/what-are-inkt-cells', '/what-are-inkt-cells/#block-65d419627ae2d198359f3796', '/publications-conference-proceedings', '/products', '/', '/pipeline', '/ala-101-car19-inkt', '/ala-105-cldn182-inkt', '/investors', '/', '/investor-centre', '/asx-announcements', '/news-presentations', '/annual-reports', '/esg-reports', '/contact', '/ala-101-car19-inkt', '/what-are-inkt-cells', '/news-presentations', '/news-presentations', 'https://www.arovella.com/news-presentations', '/s/ArovellaTherapeutics_Corporate-Presentation_2024_03.pdf', 'https://www.arovella.com/s/Arovella_Newsletter_Dec2023_v1-zhze.pdf', 'https://www.youtube.com/watch', '/what-are-inkt-cells', 'https://www.freepik.com/free-photo/pretty-korean-female-model-keeps-fit-healthy-raises-hands-shows-muscles-feels-proud-about-her-achievements-gym-smiles-broadly-dressed-white-casual-wear-poses-indoor-shows-real-power_11934092.htm#query=pretty-korean-female-model-keeps-fit-healthy-raises-hands-shows-muscles-feels-proud-about-her-achievements-gym-smiles-broadly-dressed-white-casual-wear-poses-indoor-shows-real-power&position=0&from_view=search&track=sph', 'mailto:investor@arovella.com', 'sms:+61398636472', 'https://www.bdacmedia.com', 'https://www.instagram.com/wearearovella/', 'https://twitter.com/WeAreArovella', 'https://www.linkedin.com/company/arovella-therapeutics', 'https://www.youtube.com/channel/UCBNZX1l30h2pAPcwb1rx_xA']",
    "images": "//images.squarespace-cdn.com/content/v1/611c9ee44c6800340e36efd0/ff56a299-8b41-4903-8a03-1af9ce14cf84/arovella_Large.jpg, //images.squarespace-cdn.com/content/v1/611c9ee44c6800340e36efd0/ff56a299-8b41-4903-8a03-1af9ce14cf84/arovella_Large.jpg, https://images.squarespace-cdn.com/content/v1/611c9ee44c6800340e36efd0/bbeb09e8-ed3f-4a9c-90c6-6d4102a50c93/strength-teal.jpg, https://images.squarespace-cdn.com/content/v1/611c9ee44c6800340e36efd0/2046cff5-98f6-4788-8612-9e543617ec05/Screenshot+2024-01-05+at+10.11.10.png, https://images.squarespace-cdn.com/content/v1/611c9ee44c6800340e36efd0/75ef1672-ebed-41fe-bf90-af7788576b01/Screenshot+2024-01-05+at+10.10.51.png, https://images.squarespace-cdn.com/content/v1/611c9ee44c6800340e36efd0/f139ec3c-c1ba-41a5-8e46-e3fa47ecf309/Screenshot+2024-01-05+at+10.11.38.png, https://images.squarespace-cdn.com/content/v1/611c9ee44c6800340e36efd0/c727e2ac-1747-4b61-8a9f-c322151a83da/Screenshot+2024-03-26+at+06.19.46.png, https://images.squarespace-cdn.com/content/v1/611c9ee44c6800340e36efd0/5bd2c75f-5526-48b9-9ea6-c5060f3a0d00/DNA_1.jpg",
    "company_logo_link": "https://images.squarespace-cdn.com/content/v1/611c9ee44c6800340e36efd0/bbeb09e8-ed3f-4a9c-90c6-6d4102a50c93/strength-teal.jpg"
}